Acadia is advancing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Rett syndrome, Alzheimer’s disease psychosis and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia.com and follow us on LinkedIn and Twitter.
acadia.com@companyFor more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
www.merck.com@companyFox Rothschild LLP is home to 1,000 talented attorneys covering 70+ diverse practice areas from offices coast to coast, including New York. Emerging life sciences companies, institutions, and investment firms receive the robust resources and comprehensive service of a national law firm, delivered with the razor-sharp focus and individualized attention of a boutique. Our lawyers help founders navigate a wide variety of legal, regulatory and business hurdles as they grow, seek financial backing, and develop their intellectual property.
www.foxrothschild.com/@companyCooley is the top law firm for emerging and mature life sciences and healthcare companies, investors and all those supporting the industry, and provides counsel to 1,900+ public and private life sciences and healthcare company clients worldwide, including nearly 50% of the Nasdaq Biotechnology Index. Named 2021 Life Sciences Corporate Firm of the Year by LMG and The Deal’s 2021 Healthcare, Pharma & Biotech Law Firm of the Year, the firm counsels on all aspects of life sciences technologies for established public companies and growing startups.
www.cooley.com/hub/life-sciences-test@companyMarsh McLennan Agency (MMA) provides business insurance, employee health & benefits, retirement, and private client insurance solutions to organizations and individuals seeking limitless possibilities. With over 9,900 colleagues and 170 offices across the United States and Canada, MMA combines the personalized service model of a local consultant with the global resources and expertise of the world’s leading professional services firm, Marsh McLennan (NYSE: MMC). MMA generates more than $2 billion in annualized revenue, making it one of the largest brokerage operations in North America.
For more information, visit www.MarshMMA.com. Follow Marsh McLennan Agency on LinkedIn.
BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes.
www.biomarin.com@companyEppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators and shakers. Consumables such as pipette tips, test tubes, microtiter plates, and single-use bioreactor vessels complement the range of highest-quality premium products.
www.eppendorf.com@company